SO-010 - Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors.

Saved in:
Bibliographic Details
Title: SO-010 - Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors.
Authors: Garralda, E.1 (AUTHOR), Fiedler, W.2 (AUTHOR), Matos, I.3 (AUTHOR), Rolling, C.4 (AUTHOR), Kebenko, M.4 (AUTHOR), Klinghammer, K.4 (AUTHOR), Conte, G.4 (AUTHOR), Raspagliesi, F.4 (AUTHOR), Habel, B.4 (AUTHOR), Baumeister, H.4 (AUTHOR), Ochsenreither, S.4 (AUTHOR), Zurlo, A.4 (AUTHOR)
Source: Annals of Oncology. 2019 Supplement, Vol. 30, piv125-iv125. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdz157.009